Abstract Submission

(OMB#: 0925-0740 Exp Date: 05/2019)

Abstracts for consideration as poster presentations are welcome and due by September 4th, 2018 by 11:59PM. Abstracts should be no more than 400 words. All abstracts submitted will be printed electronically and may be posted on the meeting website. Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. 

*** PLEASE REGISTER BEFORE ABSTRACT SUBMISSION *** Presenting authors must also register for the meeting as the submission of an abstract does not register you for the meeting. 

Guidelines for Abstract Submission: Please follow the guidelines below for preparing your abstract. Abstracts that do not comply with the stated specifications may be returned for editing.

Preparing Your Abstract:

  • Please use MS Word, (PC or Mac) to type your abstract. Save the abstract on your computer.
  • Format your abstract using 10-point Times font and 1-inch margins.
  • Abstracts may not be longer than one page.
  • The TITLE of your abstract should be in all uppercase letters
  • List the authors' last names and first initials in all uppercase letters, and affiliations in both uppercase and lowercase letters, directly below the title.
  • Underline the name of the presenting author.
  • Identify the corresponding affiliation and location for each author.
  • Skip one line between the listing of authors and the text of your abstract.

Example:


EARLY BREAST CANCER SCREENING IN HIV-INFECTED EASTERN EUROPEAN WOMEN 

KELLY JR1, AGBARIA R2, and PHILLIPS LP3

1Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
2Ben-Gurion University, Beer-Sheva, Israel
3Pharmacia Corporation, Nerviano, Milan, Italy

Abstract text begins here. 

Please direct any questions regarding issues relevant to abstract submissions to:
Julia Lam
301-846-6957

 

Paperwork Reduction Act (PRA): Public reporting burden for this collection of information is estimated to average of 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740).  Do not return the completed form to this address.

Contact Information

Submitting this form will NOT register you for the conference, you must use the Registration page to submit your information to secure your place as an attendee.

Abstract Information

One file only.
50 MB limit.
Allowed types: doc, docx, ppt, pptx, mov, mp4, pdf.